|
1
|
Mosconi S, Beretta GD, Labianca R, Zampino
MG, Gatta G and Heinemann V: Cholangiocarcinoma. Crit Rev Oncol
Hemat. 69:259–270. 2009. View Article : Google Scholar
|
|
2
|
Shaib Y and El-Serag HB: The epidemiology
of cholangiocarcinoma. Semin Liver Dis. 24:115–125. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang H, Yang T, Wu M and Shen F:
Intrahepatic cholangiocarcinoma: Epidemiology, risk factors,
diagnosis and surgical management. Cancer Lett. 379:198–205. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bridgewater J, Galle PR, Khan SA, Llovet
JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol. 60:1268–1289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vatanasapt V, Uttaravichien T, Mairiang
EO, Pairojkul C, Chartbanchachai W and Haswell-Elkins M:
Cholangiocarcinoma in north-east Thailand. Lancet. 335:116–117.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shin HR, Oh JK, Masuyer E, Curado MP,
Bouvard V, Fang YY, Wiangnon S, Sripa B and Hong ST: Epidemiology
of cholangiocarcinoma: An update focusing on risk factors. Cancer
Sci. 101:579–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sripa B, Bethony JM, Sithithaworn P,
Kaewkes S, Mairiang E, Loukas A, Mulvenna J, Laha T, Hotez PJ and
Brindley PJ: Opisthorchiasis and Opisthorchis-associated
cholangiocarcinoma in Thailand and Laos. Acta Trop. 120 Suppl
1:S158–S168. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luvira V, Nilprapha K, Bhudhisawasdi V,
Pugkhem A, Chamadol N and Kamsa-ard S: Cholangiocarcinoma patient
outcome in Northeastern Thailand: Single-center prospective study.
Asian Pac J Cancer Prev. 17:401–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Malhi H and Gores GJ: Cholangiocarcinoma:
Modern advances in understanding a deadly old disease. J Hepatol.
45:856–867. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sriraksa R, Zeller C, Dai W, Siddiq A,
Walley AJ, Limpaiboon T and Brown R: Aberrant DNA methylation at
genes associated with a stem cell-like phenotype in
cholangiocarcinoma tumors. Cancer Prev Res (Phila). 6:1348–1355.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McCarthy DJ and Smyth GK: Testing
significance relative to a fold-change threshold is a TREAT.
Bioinformatics. 25:765–771. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Ozawa Y, Lee H, Wen YD, Tan TH,
Wadzinski BE and Seto E: Histone deacetylase 3 (HDAC3) activity is
regulated by interaction with protein serine/threonine phosphatase
4. Genes Dev. 19:827–839. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Z, Zhang X, Xu X, Chen L, Li W, Yu H,
Sun Y, Zeng J and Jia J: RUNX3 inhibits survivin expression and
induces cell apoptosis in gastric cancer. Eur J cell Biol.
93:118–126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ju XL, Ishikawa TO, Naka K, Ito K, Ito Y
and Oshima M: Context-dependent activation of Wnt signaling by
tumor suppressor RUNX3 in gastric cancer cells. Cancer Sci.
105:418–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Imaizumi Y, Kohno T, Yamada Y, Ikeda S,
Tanaka Y, Tomonaga M and Matsuyama T: Possible involvement of
interferon regulatory factor 4 (IRF4) in a clinical subtype of
adult T-cell leukemia. Jpn J Cancer Res. 92:1284–1292. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiang T, Li L, Yin X, Yuan C, Tan C, Su X,
Xiong L, Putti TC, Oberst M, Kelly K, et al: The ubiquitin
peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis
through stabilizing p53 and is frequently silenced in breast
cancer. PLoS One. 7:e297832012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moll UM and Slade N: p63 and p73: Roles in
development and tumor formation. Mol Cancer Res. 2:371–386.
2004.PubMed/NCBI
|
|
18
|
Sicinski P, Donaher JL, Geng Y, Parker SB,
Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers
JD, et al: Cyclin D2 is an FSH-responsive gene involved in gonadal
cell proliferation and oncogenesis. Nature. 384:470–474. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shivakumar L, Minna J, Sakamaki T, Pestell
R and White MA: The RASSF1A tumor suppressor blocks cell cycle
progression and inhibits cyclin D1 accumulation. Mol Cell Biol.
22:4309–4318. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koppaka V, Thompson DC, Chen Y, Ellermann
M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD and
Vasiliou V: Aldehyde dehydrogenase inhibitors: A comprehensive
review of the pharmacology, mechanism of action, substrate
specificity and clinical application. Pharmacol Rev. 64:520–539.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garcia-Manteiga J, Molina-Arcas M, Casado
FJ, Mazo A and Pastor-Anglada M: Nucleoside transporter profiles in
human pancreatic cancer cells: Role of hCNT1 in
2′,2′-difluorodeoxycytidine-induced cytotoxicity. Clin Cancer Res.
9:5000–5008. 2003.PubMed/NCBI
|
|
22
|
Ito M, Jiang C, Krumm K, Zhang X, Pecha J,
Zhao J, Guo Y, Roeder RG and Xiao H: TIP30 deficiency increases
susceptibility to tumorigenesis. Cancer Res. 63:8763–8767.
2003.PubMed/NCBI
|
|
23
|
Donninger H, Clark J, Rinaldo F, Nelson N,
Barnoud T, Schmidt ML, Hobbing KR, Vos MD, Sils B and Clark GJ: The
RASSF1A tumor suppressor regulates XPA-mediated DNA repair. Mol
Cell Biol. 35:277–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sriraksa R, Chaopatchayakul P,
Jearanaikoon P, Leelayuwat C and Limpaiboon T: Verification of
complete bisulfite modification using Calponin-specific primer
sets. Clin Biochem. 43:528–530. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wojdacz TK, Dobrovic A and Hansen LL:
Methylation-sensitive high-resolution melting. Nat Protoc.
3:1903–1908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
NicAmhlaoibh R and Shtivelman E:
Metastasis suppressor CC3 inhibits angiogenic properties of tumor
cells in vitro. Oncogene. 20:270–275. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
King FW and Shtivelman E: Inhibition of
nuclear import by the proapoptotic protein CC3. Mol Cell Biol.
24:7091–7101. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shtivelman E: A link between metastasis
and resistance to apoptosis of variant small cell lung carcinoma.
Oncogene. 14:2167–2173. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Whitman S, Wang X, Shalaby R and
Shtivelman E: Alternatively spliced products CC3 and TC3 have
opposing effects on apoptosis. Mol Cell Biol. 20:583–593. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A,
Cong W, Liu C, Wang H, Wu M, et al: Methylation of Tip30 promoter
is associated with poor prognosis in human hepatocellular
carcinoma. Clin Cancer Res. 14:7405–7412. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen X, Cao X, Dong W, Luo S, Suo ZH and
Jin Y: Expression of TIP30 tumor suppressor gene is down-regulated
in human colorectal carcinoma. Dig Dis Sci. 55:2219–2226. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hartnett L and Egan LJ: Inflammation, DNA
methylation and colitis-associated cancer. Carcinogenesis.
33:723–731. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu J, Tao Q, Cheung KF, Jin H, Poon FF,
Wang X, Li H, Cheng YY, Rocken C, Ebert MP, et al: Epigenetic
identification of ubiquitin carboxyl-terminal hydrolase L1 as a
functional tumor suppressor and biomarker for hepatocellular
carcinoma and other digestive tumors. Hepatology. 48:508–518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Waraya M, Yamashita K, Ema A, Katada N,
Kikuchi S and Watanabe M: Exclusive association of p53 mutation
with super-high methylation of tumor suppressor genes in the p53
pathway in a unique gastric cancer phenotype. PLoS One.
10:e01399022015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu T, Jin Z, Yuan Y, Zheng H, Li C, Hou W,
Guo Q and Hua B: Tat-Interacting protein 30 (TIP30) expression
serves as a new biomarker for tumor prognosis: A systematic review
and meta-analysis. PLoS One. 11:e01684082016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu M, Yin F, Fan X, Jing W, Chen R, Liu
L, Zhang L, Liu Y, Liang Y, Bu F, et al: Decreased TIP30 promotes
Snail-mediated epithelial-mesenchymal transition and
tumor-initiating properties in hepatocellular carcinoma. Oncogene.
34:1420–1431. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu M, Yin F, Yang L, Chen S, Chen R, Zhou
X, Jing W, Fan X, Jia R, Wang H, et al: Contribution of TIP30 to
chemoresistance in laryngeal carcinoma. Cell Death Dis.
5:e14682014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao J, Zhang X, Shi M, Xu H, Jin J, Ni
HD, Yang SL, Dai JX, Wu MC and Guo YJ: TIP30 inhibits growth of HCC
cell lines and inhibits HCC xenografts in mice in combination with
5-FU. Hepatology. 44:205–215. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang C, Pecha J, Hoshino I, Ankrapp D and
Xiao H: TIP30 mutant derived from hepatocellular carcinoma
specimens promotes growth of HepG2 cells through up-regulation of
n-cadherin. Cancer Res. 67:3574–3582. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dong X, Deng Q, Nie X, Zhang M, Jia W,
Chen C, Xu C and Xu R: Downregulation of HTATIP2 expression is
associated with promoter methylation and poor prognosis in glioma.
Exp Mol Pathol. 98:192–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bonazzi VF, Nancarrow DJ, Stark MS, Moser
RJ, Boyle GM, Aoude LG, Schmidt C and Hayward NK: Cross-platform
array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as
genes frequently silenced by methylation in melanoma. PLoS One.
6:e261212011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xiang T, Li L, Yin X, Yuan C, Tan C, Su X,
Xiong L, Putti T, Oberst M, Kelly K, et al: The ubiquitin peptidase
UCHL1 induces G0/G1 cell cycle arrest and apoptosis through
stabilizing p53 and is frequently silenced in breast cancer. PLoS
One. 7:e297832012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li L, Tao Q, Jin H, van Hasselt A, Poon
FF, Wang X, Zeng MS, Jia WH, Zeng YX, Chan AT and Cao Y: The tumor
suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53
signaling and is frequently silenced in nasopharyngeal carcinoma.
Clin Cancer Res. 16:2949–2958. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Schroder C, Milde-Langosch K, Gebauer F,
Schmid K, Mueller V, Wirtz RM, Meyer-Schwesinger C, Schluter H,
Sauter G and Schumacher U: Prognostic relevance of ubiquitin
C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in
breast cancer patients. J Cancer Res Clin Oncol. 139:1745–1755.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Majchrzak-Celinska A, Paluszczak J,
Szalata M, Barciszewska AM, Nowak S and Baer-Dubowska W: DNA
methylation analysis of benign and atypical meningiomas:
Correlation between RUNX3 methylation and WHO grade. J Cancer Res
Clin Oncol. 141:1593–1601. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Majchrzak-Celinska A, Paluszczak J,
Szalata M, Barciszewska AM, Nowak S, Kleszcz R, Sherba A and
Baer-Dubowska W: The methylation of a panel of genes differentiates
low-grade from high-grade gliomas. Tumor Biol. 36:3831–3841. 2015.
View Article : Google Scholar
|
|
47
|
Ni W, Luo L, Ping Z, Yuan HP, Zhao XD and
Xu W: Prognostic value of ALDH1A3 promoter methylation in
glioblastoma: A single center experience in Western China. Asian
Pac J Cancer Prev. 16:591–594. 2015. View Article : Google Scholar : PubMed/NCBI
|
